Ridgeback Capital Investments L.P. 13D and 13G filings for F-star Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:06 pm Unchanged |
2022-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Ridgeback Capital Investments L.P. | 52,509 0.200% |
0 (Unchanged) |
Filing |
| 2023-02-14 4:02 pm Sale |
2022-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Ridgeback Capital Investments L.P. | 52,509 0.200% |
-1,781,851 (-97.14%) |
Filing |
| 2022-02-14 4:15 pm Purchase |
2021-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Ridgeback Capital Investments L.P. | 1,834,360 8.900% |
1,340,000 (+271.06%) |
Filing |
| 2021-04-09 4:54 pm Purchase |
2021-03-30 | 13G | F-star Therapeutics, Inc. FSTX |
Ridgeback Capital Investments L.P. | 494,360 5.400% |
86,793 (+21.30%) |
Filing |
| 2021-02-16 4:20 pm Purchase |
2020-12-31 | 13G | F-star Therapeutics, Inc. FSTX |
Ridgeback Capital Investments L.P. | 407,567 4.500% |
407,567 (New Position) |
Filing |